Aspira Womens Health Inc (FRA:CUL)
€ 1.85 -0.01 (-0.54%) Market Cap: 24.01 Mil Enterprise Value: 23.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Q1 2022 Aspira Women's Health Inc Earnings Call Transcript

May 11, 2022 / 12:30PM GMT
Release Date Price: €7.38 (-8.04%)
Nicole Sandford;s Health Inc.;President
Aspira Women;CEO & Director

'- -

Thank you, operator, and thank you to all of you for joining us today. I'll start with a business update before I hand the call over to Bob to review our Q1 financial performance. Our Commercial Leader, Michael Newton; and Executive Chairwoman, Valerie Palmieri, are also here with us and will be available for questions later in the call.

During my first 2 months as CEO of Aspira, I have focused on validating our strategic priorities and aligning resources to the areas of the business that we believe are most likely to contribute to short and long-term growth. That effort has included focusing our attention on volume growth in our core business, allocating R&D resources to the products that we believe are most likely to drive commercial success and rationalizing our cash usage across the business. As I said the last time we were together, I believe the ability to achieve our mission to improve the health outcomes of women with gynecological diseases relies on our ability to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot